www.fgks.org   »   [go: up one dir, main page]

SlideShare a Scribd company logo
Capturing drugs, leads and targets in the
IUPHAR/MMV Guide to Malaria Pharmacology
C. Southan1, J. F. Armstrong1, E. Faccenda1, S. D. Harding1, J. L.
Sharman1, A. J. Pawson1, J Gamo2,3 B Campo2, J. A. Davies1
M. Spedding4, S.P.H. Alexander4
1) IUPHAR/BPS Guide to Pharmacology, Centre for Discovery Brain Sciences, University of
Edinburgh, UK., 2) Medicines for Malaria Venture, Geneva, Switzerland, 3) Tres Cantos
Medicines Development Campus, GlaxoSmithKline, Spain, 4) International Union of Basic &
Clinical Pharmacology (IUPHAR)
1
World Congress of Pharmacology, Kyoto, Global Infectious Diseases session,
Wednesday, July 4, 2018
Abstract (will not be presented)
Introduction: GtoPdb has been traditionally focused on the pharmacology associated with non-infectious
diseases. However, in October of 2017 we initiated a collaboration with Medicines for MalariaVenture (MMV) in
Geneva, where we have been piloting the curation of antimalarial compounds and Plasmodium targets for
approved drugs and the global portfolio of new clinical candidates and research leads .This will provide explicit
mappings between compounds and targets for current and new antimalarials.
Methods:The main method is mining primary literature, review articles to collate an open CiteUlike tagged
collection . For database entries, drugs and leads are prioritised for having a) specific chemical structure, b) a
reported potency for antimalarial activity in vitro and, where possible c) activity data against the purified
Plasmodium target and d) in vivo/ clinical data. We map chemical structures to PubChemCompound Identifiers
(CIDs) and assign Plasmodium target proteins to UniProt accession numbers. These are accommodated within
GtoPdb under a new classification of “antinfective targets”
Results: We have successfully adapted GtoPdb data model for Plasmodium target mapping. However, sub-
species and strain isolates may produce equivocality as to the exact sequence targeted. Whilst some
publications are from open drug discovery practitioners, we can map most lead compounds to their
corresponding patents via SureChEMBL. We can also accommodate lead structures with unknown mechanisms
of parasite killing. Our first curated leads have been submitted to PubChem (e.g. SID 340590277 against N-
Myristoyltransferase, UniProt Q8ILW6)
Conclusion We have curated antimalarial relationship mappings into GtoPdb and surfaced these in our public
release. We are now expanding to triage more publications. Our initiative enhances the facility with which the
antimalarial community can access lead, target and efficacy data integrated between disparate global R&D
efforts.This will support reciprocal cross-screening of leads for mechanistic investigations, target
deconvolution, 3D structures and homology-based cross-screening directed against apicomplexan parasites.
2
Overview of Guide to PHARMACOLOGY (GtoPdb)
expert curated relationships
(PMID 29149325 and poster PO2-8-11)
• Total number of ligands = 9251
• Ligands with PubChem chemical structure entries (C) = 7070
• PubMed IDs associated with these by us (D) = 8109
• Human targets with quantitative interactions (P) = 1467
• Number of curated binding constants (R) = 15851
• Data from release 2018.2 http://www.guidetopharmacology.org/about.jsp
3
Document > assay > result > compound > location > protein target
D- A- R - C- L- P
Motivation for establishing the IUPHAR/MMV
Guide to Malaria Pharmacology (GtoMPdb)
• Engagement by MMV, their collaborators and many research teams globaly,
some with an Open Source Drug Discovery modus operandi, has accelerated
the generation of new antimalarial leads and clinical candidates
• However, finding links between publications, code names, chemical structures,
activity data and molecular mechanisms of action (mmoa), (including
Plasmodium target sequences) is challenging
• It remains an anachronism that neither authors nor journals submit chemical
structures, code names or target associations of new antimalarials to databases
• These “lost linkages” have problematic consequences, e.g. hindering data-
mining, exchange of compounds for cross-screening, omics profiling and
deconvolution of unknown mmoa
• The GtoPdb data model has already proved flexible in its adaptation to the
Guide to Immunopharmacology and pilot studies indicated that curated
antimalarial relationships could also be accomodated
4

Recommended for you

Harding_ImmunopharmacologyWorkshop_Pharmacology2019
Harding_ImmunopharmacologyWorkshop_Pharmacology2019Harding_ImmunopharmacologyWorkshop_Pharmacology2019
Harding_ImmunopharmacologyWorkshop_Pharmacology2019

Workshop on Using the Guide to Immunoipharmacology. PDF of slides presented at BPS Pharmacology 2019 by Dr. Simon Harding.

immunopharmacologydatabasepharmacology
Structure identification by Mass Spectrometry Non-Targeted Analysis using the...
Structure identification by Mass Spectrometry Non-Targeted Analysis using the...Structure identification by Mass Spectrometry Non-Targeted Analysis using the...
Structure identification by Mass Spectrometry Non-Targeted Analysis using the...

Identification of unknowns in mass spectrometry based non-targeted analyses (NTA) requires the integration of complementary pieces of data to arrive at a confident, consensus structure. Researchers use chemical reference databases, spectral matching, fragment prediction tools, retention time prediction tools, and a variety of other data to arrive at tentative, probable, and confirmed, if possible, identifications. With the diverse, robust data contained within the US EPA’s CompTox Chemistry Dashboard (https://comptox.epa.gov), the goal of this research is to identify and implement a harmonized identification tool and workflow using previously generated chemistry data. Data has been compiled from product use, functional use prediction models, environmental media occurrence prediction models, and PubMed references, among other sources. We will report on our development of a visualization tool whereby users can visualize the relative contribution of identification-based metrics on a list of candidate structures and observe the greatest likelihood of occurrence. These data and visualization tools support NTA identification via the Dashboard and demonstrate an open, accessible tool for all users of HRMS data. This abstract does not necessarily represent the views or policies of the U.S. Environmental Protection Agency.

mass spectrometrynon-targeted screeningstructure identification
Will the correct drugs please stand up?
Will  the correct drugs please stand up?Will  the correct drugs please stand up?
Will the correct drugs please stand up?

This document summarizes a study comparing different databases of approved drug structures mapped to PubChem identifiers (CIDs). The study found significant discordances between sources, with little consensus on total numbers of approved drugs or their structures. Only 183 structures were common to all 8 sources compared. The sources exhibited extensive structural multiplexing, with the same structure represented by multiple CIDs. This multiplexing extends beyond approved drugs and poses challenges for tasks like QSAR. Improved curation and direct submission of structures from drug developers could help resolve inconsistencies.

pharmaceutical drugspubchem
Using CiteUlike for open pre-curation
5
Database example for OSM-S-38
6
Portal
alpha
release
7
Liver stage examples
8

Recommended for you

Assessing GtoPdb ligand content in PubChem
Assessing GtoPdb ligand content in PubChemAssessing GtoPdb ligand content in PubChem
Assessing GtoPdb ligand content in PubChem

The document discusses the content of ligands from the IUPHAR/BPS Guide to PHARMACOLOGY database (GtoPdb) that is contained within PubChem. It finds that GtoPdb ligands have extensive overlap with several other sources within PubChem, including patents, DrugBank, vendor structures, bioassays, and ChEMBL. This overlap allows users to find additional information on GtoPdb ligands from these complementary sources within PubChem.

databasepubchem
IUPHAR/BPS Guide to Pharmacology: concise mapping of chemistry, data, and tar...
IUPHAR/BPS Guide to Pharmacology: concise mapping of chemistry, data, and tar...IUPHAR/BPS Guide to Pharmacology: concise mapping of chemistry, data, and tar...
IUPHAR/BPS Guide to Pharmacology: concise mapping of chemistry, data, and tar...

The document summarizes the IUPHAR/BPS Guide to Pharmacology (GtoPdb) database, which maps relationships between chemistry, data, and protein targets. It has evolved from earlier databases to now include over 1500 human protein targets linked to ligand data. Challenges include resolving relationships across different target hierarchies and filling data gaps. Future plans include expanding the database and linking it to immunopharmacology data through a new Guide to Immunopharmacology portal.

bio-activity database pubchem chemistry drug ta
Open Phenotypic Drug Discovery Resource poster
Open Phenotypic Drug Discovery Resource posterOpen Phenotypic Drug Discovery Resource poster
Open Phenotypic Drug Discovery Resource poster

Open Phenotypic Drug Discovery Resource poster, presented at Open PHACTS Conference "Linking Life Science Data", Feb 18-19, 2016, University of Vienna

linked datadrug discoveryopen science
Ligand listing
9
Ligand matches to PubChem entries
• All 28 curated ligands so far
• We will submit these, including
future novels
• They will get PubMed links for our
references
• Query “Guide to Malaria
Pharmacology” will retrieve our
submissions
• 22 are ”Rule of 5”
• 4 are not in ChEMBL
• 26 have SureChEMBL patent
extraction matches
• Only 15 are tagged ”Antimalarials”
in PubChem
• 14 have vendor matches
• Some do not have the code
numbers we have matched (but
will when we submit)
10
Data-supported targets vs unknown mmoa
11
Target proteins with direct binding data, strong genetic inference or cell screening
evidence
From the current 28 ligands the mechanistic target evidence: unknown mmoa is ~ 2:1
(but this is shifting as curation proceeds)
Achievments and plans
• Adapting the GtoPdb schema and expert curation approaches to antimalarial
compounds and targets has been sucessful
• We hope this systematic ”global portfolio” capture will contribute to progress
• The first set of records wil go live in GtoPdb release ~July 2018 and then be
submitted to PubChem
• Develpment of the Alpha portal is progressing via feedback from MMV, a
constituted Expert Commitee and initial users
• Some malaria-specific challenges still need optimisation, e.g. separating
IC50 potency for parasite killing in vivo from inhibition IC50 against purified
targets in vitro
• CiteUlike capture and curation of mechanistic papers
• The comunity can alert us to new antimalarial lead papers (e.g. use our open
CiteUlike tags)
• Consider pre-publication capture (e.g. Sydney Open Source Malaria team)
• Check for patents with new SAR not yet in journals 12

Recommended for you

The IUPHAR/BPS Guide to PHARAMCOLOGY in 2018: new features and updates
The IUPHAR/BPS Guide to PHARAMCOLOGY in 2018: new features and updatesThe IUPHAR/BPS Guide to PHARAMCOLOGY in 2018: new features and updates
The IUPHAR/BPS Guide to PHARAMCOLOGY in 2018: new features and updates

2018 update poster for the IUPHAR/BPS Guide to PHARMACOLOGY. Giving details of new features and updates. To be presented at Pharmacology Futures, Edinburgh, May 2018; ELIXIR-All Hands, Berlin, June 2018 and World Congress of Pharmacology, Kyoto, Japan, July 2018

pharmacologydatabasedrug targets
Using the US EPA’s CompTox Chemistry Dashboard for structure identification a...
Using the US EPA’s CompTox Chemistry Dashboard for structure identification a...Using the US EPA’s CompTox Chemistry Dashboard for structure identification a...
Using the US EPA’s CompTox Chemistry Dashboard for structure identification a...

High resolution mass spectrometry (HRMS) and non-targeted analysis (NTA) are advancing the identification of emerging contaminants in environmental matrices, improving the means by which exposure analyses can be conducted. However, confidence in structure identification of unknowns in NTA presents challenges to analytical chemists. Structure identification requires integration of complementary data types such as reference databases, fragmentation prediction tools, and retention time prediction models. The goal of this research is to optimize and implement structure identification functionality within the US EPA’s CompTox Chemistry Dashboard, an open chemistry resource and web application containing data for ~760,000 substances. Rank-ordering the number of sources associated with chemical records within the Dashboard (Data Source Ranking) improves the identification of unknowns by bringing the most likely candidate structures to the top of a search results list. Database searching has been further optimized with the generation of MS-Ready Structures. MS-Ready structures are de-salted, stripped of stereochemistry, and mixture separated to replicate the form of a chemical observed via HRMS. Functionality to conduct batch searching of molecular formulae and monoisotopic masses was designed and released to improve searching efforts. Finally, a scoring-based identification scheme was developed, optimized, and surfaced via the Dashboard using multiple data streams contained within the database underlying the Dashboard. The scoring-based identification scheme improved the identification of unknowns over previous efforts using data source ranking alone. Combining these steps within an open chemistry resource provides a freely available software tool for structure identification and NTA. This abstract does not necessarily represent the views or policies of the U.S. Environmental Protection Agency.

comptox dashboardchemistry dataopen data for chemistry
Accessing information for chemicals in hydraulic fracturing fluids using the ...
Accessing information for chemicals in hydraulic fracturing fluids using the ...Accessing information for chemicals in hydraulic fracturing fluids using the ...
Accessing information for chemicals in hydraulic fracturing fluids using the ...

The document describes the EPA's CompTox Chemistry Dashboard, which provides access to data on over 760,000 chemicals. It focuses on how the Dashboard can be used to access information on chemicals used in hydraulic fracturing. Key features include searching for chemicals by name or formula, viewing associated property and hazard data, and links to other resources. The process of curating chemical lists from sources like EPA's hydraulic fracturing study involves mapping names to CAS numbers and structures through iterative checking. This allows accessing additional screening data, exposure information, and integrating identifiers to support searches.

hydraulic fracturingmass spectrometrycheminformatics
Questions
and further
info
https://cdsouthan.blogspot.com/2017/08/name
-to-struc-resolution-for-yet.html?q=antimalarial

More Related Content

What's hot

IUPHAR/BPS Guide to Pharmacology
IUPHAR/BPS Guide to PharmacologyIUPHAR/BPS Guide to Pharmacology
IUPHAR/BPS Guide to Pharmacology
Guide to PHARMACOLOGY
 
Multiplexing analysis of 1000 approved drugs in PubChem
Multiplexing analysis of 1000 approved drugs in PubChemMultiplexing analysis of 1000 approved drugs in PubChem
Multiplexing analysis of 1000 approved drugs in PubChem
Chris Southan
 
Curatorial data wrangling for the Guide to PHARMACOLGY
Curatorial data wrangling for the Guide to PHARMACOLGY Curatorial data wrangling for the Guide to PHARMACOLGY
Curatorial data wrangling for the Guide to PHARMACOLGY
Chris Southan
 
Harding_ImmunopharmacologyWorkshop_Pharmacology2019
Harding_ImmunopharmacologyWorkshop_Pharmacology2019Harding_ImmunopharmacologyWorkshop_Pharmacology2019
Harding_ImmunopharmacologyWorkshop_Pharmacology2019
Guide to PHARMACOLOGY
 
Structure identification by Mass Spectrometry Non-Targeted Analysis using the...
Structure identification by Mass Spectrometry Non-Targeted Analysis using the...Structure identification by Mass Spectrometry Non-Targeted Analysis using the...
Structure identification by Mass Spectrometry Non-Targeted Analysis using the...
US Environmental Protection Agency (EPA), Center for Computational Toxicology and Exposure
 
Will the correct drugs please stand up?
Will  the correct drugs please stand up?Will  the correct drugs please stand up?
Will the correct drugs please stand up?
Chris Southan
 
Assessing GtoPdb ligand content in PubChem
Assessing GtoPdb ligand content in PubChemAssessing GtoPdb ligand content in PubChem
Assessing GtoPdb ligand content in PubChem
Chris Southan
 
IUPHAR/BPS Guide to Pharmacology: concise mapping of chemistry, data, and tar...
IUPHAR/BPS Guide to Pharmacology: concise mapping of chemistry, data, and tar...IUPHAR/BPS Guide to Pharmacology: concise mapping of chemistry, data, and tar...
IUPHAR/BPS Guide to Pharmacology: concise mapping of chemistry, data, and tar...
Chris Southan
 
Open Phenotypic Drug Discovery Resource poster
Open Phenotypic Drug Discovery Resource posterOpen Phenotypic Drug Discovery Resource poster
Open Phenotypic Drug Discovery Resource poster
Jeremy Yang
 
The IUPHAR/BPS Guide to PHARAMCOLOGY in 2018: new features and updates
The IUPHAR/BPS Guide to PHARAMCOLOGY in 2018: new features and updatesThe IUPHAR/BPS Guide to PHARAMCOLOGY in 2018: new features and updates
The IUPHAR/BPS Guide to PHARAMCOLOGY in 2018: new features and updates
Guide to PHARMACOLOGY
 
Using the US EPA’s CompTox Chemistry Dashboard for structure identification a...
Using the US EPA’s CompTox Chemistry Dashboard for structure identification a...Using the US EPA’s CompTox Chemistry Dashboard for structure identification a...
Using the US EPA’s CompTox Chemistry Dashboard for structure identification a...
US Environmental Protection Agency (EPA), Center for Computational Toxicology and Exposure
 
Accessing information for chemicals in hydraulic fracturing fluids using the ...
Accessing information for chemicals in hydraulic fracturing fluids using the ...Accessing information for chemicals in hydraulic fracturing fluids using the ...
Accessing information for chemicals in hydraulic fracturing fluids using the ...
US Environmental Protection Agency (EPA), Center for Computational Toxicology and Exposure
 
Rmc phenotypic screening
Rmc phenotypic screeningRmc phenotypic screening
Rmc phenotypic screening
Ann-Marie Roche
 
The EPA Comptox Chemistry Dashboard: A Web-Based Data Integration Hub for Tox...
The EPA Comptox Chemistry Dashboard: A Web-Based Data Integration Hub for Tox...The EPA Comptox Chemistry Dashboard: A Web-Based Data Integration Hub for Tox...
The EPA Comptox Chemistry Dashboard: A Web-Based Data Integration Hub for Tox...
US Environmental Protection Agency (EPA), Center for Computational Toxicology and Exposure
 
Antimalarial drug dscovery data disclosure
Antimalarial drug dscovery data disclosureAntimalarial drug dscovery data disclosure
Antimalarial drug dscovery data disclosure
Chris Southan
 
Applicationsofbioinformaticsindrugdiscoveryandprocess
ApplicationsofbioinformaticsindrugdiscoveryandprocessApplicationsofbioinformaticsindrugdiscoveryandprocess
Applicationsofbioinformaticsindrugdiscoveryandprocess
jaidev53ster
 
The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...
The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...
The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...
Andrew McEachran
 
Patent chemisty big bang: utilities for SMEs
Patent chemisty big bang: utilities for SMEsPatent chemisty big bang: utilities for SMEs
Patent chemisty big bang: utilities for SMEs
Chris Southan
 
Capturing BIA-10-2474 and related FAAH inhibitor data
Capturing BIA-10-2474 and related FAAH inhibitor dataCapturing BIA-10-2474 and related FAAH inhibitor data
Capturing BIA-10-2474 and related FAAH inhibitor data
Chris Southan
 
New developments in delivering public access to data from the National Center...
New developments in delivering public access to data from the National Center...New developments in delivering public access to data from the National Center...
New developments in delivering public access to data from the National Center...
US Environmental Protection Agency (EPA), Center for Computational Toxicology and Exposure
 

What's hot (20)

IUPHAR/BPS Guide to Pharmacology
IUPHAR/BPS Guide to PharmacologyIUPHAR/BPS Guide to Pharmacology
IUPHAR/BPS Guide to Pharmacology
 
Multiplexing analysis of 1000 approved drugs in PubChem
Multiplexing analysis of 1000 approved drugs in PubChemMultiplexing analysis of 1000 approved drugs in PubChem
Multiplexing analysis of 1000 approved drugs in PubChem
 
Curatorial data wrangling for the Guide to PHARMACOLGY
Curatorial data wrangling for the Guide to PHARMACOLGY Curatorial data wrangling for the Guide to PHARMACOLGY
Curatorial data wrangling for the Guide to PHARMACOLGY
 
Harding_ImmunopharmacologyWorkshop_Pharmacology2019
Harding_ImmunopharmacologyWorkshop_Pharmacology2019Harding_ImmunopharmacologyWorkshop_Pharmacology2019
Harding_ImmunopharmacologyWorkshop_Pharmacology2019
 
Structure identification by Mass Spectrometry Non-Targeted Analysis using the...
Structure identification by Mass Spectrometry Non-Targeted Analysis using the...Structure identification by Mass Spectrometry Non-Targeted Analysis using the...
Structure identification by Mass Spectrometry Non-Targeted Analysis using the...
 
Will the correct drugs please stand up?
Will  the correct drugs please stand up?Will  the correct drugs please stand up?
Will the correct drugs please stand up?
 
Assessing GtoPdb ligand content in PubChem
Assessing GtoPdb ligand content in PubChemAssessing GtoPdb ligand content in PubChem
Assessing GtoPdb ligand content in PubChem
 
IUPHAR/BPS Guide to Pharmacology: concise mapping of chemistry, data, and tar...
IUPHAR/BPS Guide to Pharmacology: concise mapping of chemistry, data, and tar...IUPHAR/BPS Guide to Pharmacology: concise mapping of chemistry, data, and tar...
IUPHAR/BPS Guide to Pharmacology: concise mapping of chemistry, data, and tar...
 
Open Phenotypic Drug Discovery Resource poster
Open Phenotypic Drug Discovery Resource posterOpen Phenotypic Drug Discovery Resource poster
Open Phenotypic Drug Discovery Resource poster
 
The IUPHAR/BPS Guide to PHARAMCOLOGY in 2018: new features and updates
The IUPHAR/BPS Guide to PHARAMCOLOGY in 2018: new features and updatesThe IUPHAR/BPS Guide to PHARAMCOLOGY in 2018: new features and updates
The IUPHAR/BPS Guide to PHARAMCOLOGY in 2018: new features and updates
 
Using the US EPA’s CompTox Chemistry Dashboard for structure identification a...
Using the US EPA’s CompTox Chemistry Dashboard for structure identification a...Using the US EPA’s CompTox Chemistry Dashboard for structure identification a...
Using the US EPA’s CompTox Chemistry Dashboard for structure identification a...
 
Accessing information for chemicals in hydraulic fracturing fluids using the ...
Accessing information for chemicals in hydraulic fracturing fluids using the ...Accessing information for chemicals in hydraulic fracturing fluids using the ...
Accessing information for chemicals in hydraulic fracturing fluids using the ...
 
Rmc phenotypic screening
Rmc phenotypic screeningRmc phenotypic screening
Rmc phenotypic screening
 
The EPA Comptox Chemistry Dashboard: A Web-Based Data Integration Hub for Tox...
The EPA Comptox Chemistry Dashboard: A Web-Based Data Integration Hub for Tox...The EPA Comptox Chemistry Dashboard: A Web-Based Data Integration Hub for Tox...
The EPA Comptox Chemistry Dashboard: A Web-Based Data Integration Hub for Tox...
 
Antimalarial drug dscovery data disclosure
Antimalarial drug dscovery data disclosureAntimalarial drug dscovery data disclosure
Antimalarial drug dscovery data disclosure
 
Applicationsofbioinformaticsindrugdiscoveryandprocess
ApplicationsofbioinformaticsindrugdiscoveryandprocessApplicationsofbioinformaticsindrugdiscoveryandprocess
Applicationsofbioinformaticsindrugdiscoveryandprocess
 
The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...
The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...
The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...
 
Patent chemisty big bang: utilities for SMEs
Patent chemisty big bang: utilities for SMEsPatent chemisty big bang: utilities for SMEs
Patent chemisty big bang: utilities for SMEs
 
Capturing BIA-10-2474 and related FAAH inhibitor data
Capturing BIA-10-2474 and related FAAH inhibitor dataCapturing BIA-10-2474 and related FAAH inhibitor data
Capturing BIA-10-2474 and related FAAH inhibitor data
 
New developments in delivering public access to data from the National Center...
New developments in delivering public access to data from the National Center...New developments in delivering public access to data from the National Center...
New developments in delivering public access to data from the National Center...
 

Similar to The IUPHAR/MMV Guide to Malaria Pharmacology

Drug-to-protein mappings in the Guide to PHARMACOLOGY: Utility as a target va...
Drug-to-protein mappings in the Guide to PHARMACOLOGY: Utility as a target va...Drug-to-protein mappings in the Guide to PHARMACOLOGY: Utility as a target va...
Drug-to-protein mappings in the Guide to PHARMACOLOGY: Utility as a target va...
Guide to PHARMACOLOGY
 
IUPHAR Guide to IMMUNOPHARMACOLOGY Poster - Pharmacology 2016
IUPHAR Guide to IMMUNOPHARMACOLOGY Poster - Pharmacology 2016IUPHAR Guide to IMMUNOPHARMACOLOGY Poster - Pharmacology 2016
IUPHAR Guide to IMMUNOPHARMACOLOGY Poster - Pharmacology 2016
Guide to PHARMACOLOGY
 
Druggable Proteome sources in UniProt
Druggable Proteome sources in UniProtDruggable Proteome sources in UniProt
Druggable Proteome sources in UniProt
Chris Southan
 
Druggable genome in GtoPdb and other dbs
Druggable genome in GtoPdb and other dbsDruggable genome in GtoPdb and other dbs
Druggable genome in GtoPdb and other dbs
Chris Southan
 
Analysing targets and drugs to populate the GToP database
Analysing  targets and drugs to populate the GToP databaseAnalysing  targets and drugs to populate the GToP database
Analysing targets and drugs to populate the GToP database
Chris Southan
 
IUPHAR Guide to IMMUNOPHARMACOLOGY
IUPHAR Guide to IMMUNOPHARMACOLOGYIUPHAR Guide to IMMUNOPHARMACOLOGY
IUPHAR Guide to IMMUNOPHARMACOLOGY
Guide to PHARMACOLOGY
 
MedImmune Industrial Placement Student Programme 2016
MedImmune Industrial Placement Student Programme 2016MedImmune Industrial Placement Student Programme 2016
MedImmune Industrial Placement Student Programme 2016
Jonathan Duckworth
 
Guide to PHARMACOLOGY: a web-Based Compendium for Research and Education
Guide to PHARMACOLOGY: a web-Based Compendium for Research and EducationGuide to PHARMACOLOGY: a web-Based Compendium for Research and Education
Guide to PHARMACOLOGY: a web-Based Compendium for Research and Education
Chris Southan
 
★★★2019 Quantitative Systems Pharmacology for Drug Discovery and Development.pdf
★★★2019 Quantitative Systems Pharmacology for Drug Discovery and Development.pdf★★★2019 Quantitative Systems Pharmacology for Drug Discovery and Development.pdf
★★★2019 Quantitative Systems Pharmacology for Drug Discovery and Development.pdf
tony749601
 
TIGA: Target Illumination GWAS Analytics
TIGA: Target Illumination GWAS AnalyticsTIGA: Target Illumination GWAS Analytics
TIGA: Target Illumination GWAS Analytics
Jeremy Yang
 
oct.13 tips NTN
oct.13 tips NTN oct.13 tips NTN
oct.13 tips NTN
Nitin Kshirsagar MS(Pharm)
 
Oct.13 tips ntn
Oct.13 tips ntn Oct.13 tips ntn
Oct.13 tips ntn
Nitin Kshirsagar MS(Pharm)
 
Significance of computational tools in drug discovery
Significance of computational tools in drug discoverySignificance of computational tools in drug discovery
Significance of computational tools in drug discovery
DrMopuriDeepaReddy
 
Amia tbi-14-final
Amia tbi-14-finalAmia tbi-14-final
Amia tbi-14-final
Russ Altman
 
IUPHAR Guide to IMMUNOPHARMACOLOGY
IUPHAR Guide to IMMUNOPHARMACOLOGYIUPHAR Guide to IMMUNOPHARMACOLOGY
IUPHAR Guide to IMMUNOPHARMACOLOGY
Guide to PHARMACOLOGY
 
Advances in computer aided drug design
Advances in computer aided drug designAdvances in computer aided drug design
Advances in computer aided drug design
Vikas Soni
 
87560480 a-study-on-computer-aided-drug-design-for-m2-protein-in-h1 n1
87560480 a-study-on-computer-aided-drug-design-for-m2-protein-in-h1 n187560480 a-study-on-computer-aided-drug-design-for-m2-protein-in-h1 n1
87560480 a-study-on-computer-aided-drug-design-for-m2-protein-in-h1 n1
Anitha1408
 
Analysing curated protein targets: Partitioning the drugged and the druggable
Analysing curated protein targets: Partitioning the drugged and the druggable Analysing curated protein targets: Partitioning the drugged and the druggable
Analysing curated protein targets: Partitioning the drugged and the druggable
Chris Southan
 
IUPHAR Guide to IMMUNOPHARMACOLOGY
IUPHAR Guide to IMMUNOPHARMACOLOGYIUPHAR Guide to IMMUNOPHARMACOLOGY
IUPHAR Guide to IMMUNOPHARMACOLOGY
Guide to PHARMACOLOGY
 
GtoImmuPdb_2017
GtoImmuPdb_2017GtoImmuPdb_2017
GtoImmuPdb_2017
Guide to PHARMACOLOGY
 

Similar to The IUPHAR/MMV Guide to Malaria Pharmacology (20)

Drug-to-protein mappings in the Guide to PHARMACOLOGY: Utility as a target va...
Drug-to-protein mappings in the Guide to PHARMACOLOGY: Utility as a target va...Drug-to-protein mappings in the Guide to PHARMACOLOGY: Utility as a target va...
Drug-to-protein mappings in the Guide to PHARMACOLOGY: Utility as a target va...
 
IUPHAR Guide to IMMUNOPHARMACOLOGY Poster - Pharmacology 2016
IUPHAR Guide to IMMUNOPHARMACOLOGY Poster - Pharmacology 2016IUPHAR Guide to IMMUNOPHARMACOLOGY Poster - Pharmacology 2016
IUPHAR Guide to IMMUNOPHARMACOLOGY Poster - Pharmacology 2016
 
Druggable Proteome sources in UniProt
Druggable Proteome sources in UniProtDruggable Proteome sources in UniProt
Druggable Proteome sources in UniProt
 
Druggable genome in GtoPdb and other dbs
Druggable genome in GtoPdb and other dbsDruggable genome in GtoPdb and other dbs
Druggable genome in GtoPdb and other dbs
 
Analysing targets and drugs to populate the GToP database
Analysing  targets and drugs to populate the GToP databaseAnalysing  targets and drugs to populate the GToP database
Analysing targets and drugs to populate the GToP database
 
IUPHAR Guide to IMMUNOPHARMACOLOGY
IUPHAR Guide to IMMUNOPHARMACOLOGYIUPHAR Guide to IMMUNOPHARMACOLOGY
IUPHAR Guide to IMMUNOPHARMACOLOGY
 
MedImmune Industrial Placement Student Programme 2016
MedImmune Industrial Placement Student Programme 2016MedImmune Industrial Placement Student Programme 2016
MedImmune Industrial Placement Student Programme 2016
 
Guide to PHARMACOLOGY: a web-Based Compendium for Research and Education
Guide to PHARMACOLOGY: a web-Based Compendium for Research and EducationGuide to PHARMACOLOGY: a web-Based Compendium for Research and Education
Guide to PHARMACOLOGY: a web-Based Compendium for Research and Education
 
★★★2019 Quantitative Systems Pharmacology for Drug Discovery and Development.pdf
★★★2019 Quantitative Systems Pharmacology for Drug Discovery and Development.pdf★★★2019 Quantitative Systems Pharmacology for Drug Discovery and Development.pdf
★★★2019 Quantitative Systems Pharmacology for Drug Discovery and Development.pdf
 
TIGA: Target Illumination GWAS Analytics
TIGA: Target Illumination GWAS AnalyticsTIGA: Target Illumination GWAS Analytics
TIGA: Target Illumination GWAS Analytics
 
oct.13 tips NTN
oct.13 tips NTN oct.13 tips NTN
oct.13 tips NTN
 
Oct.13 tips ntn
Oct.13 tips ntn Oct.13 tips ntn
Oct.13 tips ntn
 
Significance of computational tools in drug discovery
Significance of computational tools in drug discoverySignificance of computational tools in drug discovery
Significance of computational tools in drug discovery
 
Amia tbi-14-final
Amia tbi-14-finalAmia tbi-14-final
Amia tbi-14-final
 
IUPHAR Guide to IMMUNOPHARMACOLOGY
IUPHAR Guide to IMMUNOPHARMACOLOGYIUPHAR Guide to IMMUNOPHARMACOLOGY
IUPHAR Guide to IMMUNOPHARMACOLOGY
 
Advances in computer aided drug design
Advances in computer aided drug designAdvances in computer aided drug design
Advances in computer aided drug design
 
87560480 a-study-on-computer-aided-drug-design-for-m2-protein-in-h1 n1
87560480 a-study-on-computer-aided-drug-design-for-m2-protein-in-h1 n187560480 a-study-on-computer-aided-drug-design-for-m2-protein-in-h1 n1
87560480 a-study-on-computer-aided-drug-design-for-m2-protein-in-h1 n1
 
Analysing curated protein targets: Partitioning the drugged and the druggable
Analysing curated protein targets: Partitioning the drugged and the druggable Analysing curated protein targets: Partitioning the drugged and the druggable
Analysing curated protein targets: Partitioning the drugged and the druggable
 
IUPHAR Guide to IMMUNOPHARMACOLOGY
IUPHAR Guide to IMMUNOPHARMACOLOGYIUPHAR Guide to IMMUNOPHARMACOLOGY
IUPHAR Guide to IMMUNOPHARMACOLOGY
 
GtoImmuPdb_2017
GtoImmuPdb_2017GtoImmuPdb_2017
GtoImmuPdb_2017
 

More from Chris Southan

FAIR connectivity for DARCP
FAIR  connectivity for DARCPFAIR  connectivity for DARCP
FAIR connectivity for DARCP
Chris Southan
 
Connectivity > documents > structures > bioactivity
Connectivity > documents > structures > bioactivityConnectivity > documents > structures > bioactivity
Connectivity > documents > structures > bioactivity
Chris Southan
 
Peptide tribulations
Peptide tribulationsPeptide tribulations
Peptide tribulations
Chris Southan
 
Vicissitudes of target validation for BACE1 and BACE2
Vicissitudes of target validation for BACE1 and BACE2 Vicissitudes of target validation for BACE1 and BACE2
Vicissitudes of target validation for BACE1 and BACE2
Chris Southan
 
Guide to Pharmacology database: ELIXIR updae
Guide to Pharmacology database: ELIXIR updaeGuide to Pharmacology database: ELIXIR updae
Guide to Pharmacology database: ELIXIR updae
Chris Southan
 
In silico 360 Analysis for Drug Development
In silico 360 Analysis for Drug DevelopmentIn silico 360 Analysis for Drug Development
In silico 360 Analysis for Drug Development
Chris Southan
 
Will the correct BACE ORFs please stand up?
Will the correct BACE ORFs please stand up?Will the correct BACE ORFs please stand up?
Will the correct BACE ORFs please stand up?
Chris Southan
 
Desperately seeking DARCP
Desperately seeking DARCPDesperately seeking DARCP
Desperately seeking DARCP
Chris Southan
 
Seeking glimmers of light in Pharos “Tdark” proteins
Seeking glimmers of light in  Pharos “Tdark” proteinsSeeking glimmers of light in  Pharos “Tdark” proteins
Seeking glimmers of light in Pharos “Tdark” proteins
Chris Southan
 
5HT2A modulators update for SAFER
5HT2A modulators update for SAFER5HT2A modulators update for SAFER
5HT2A modulators update for SAFER
Chris Southan
 
Quality and noise in big chemistry databases
Quality and noise in big chemistry databasesQuality and noise in big chemistry databases
Quality and noise in big chemistry databases
Chris Southan
 
Connecting chemistry-to-biology
Connecting chemistry-to-biology Connecting chemistry-to-biology
Connecting chemistry-to-biology
Chris Southan
 
GtoPdb June 2019 poster
GtoPdb June 2019 posterGtoPdb June 2019 poster
GtoPdb June 2019 poster
Chris Southan
 
PubChem as a source of systems biology perturbagens
PubChem as a source of  systems biology perturbagensPubChem as a source of  systems biology perturbagens
PubChem as a source of systems biology perturbagens
Chris Southan
 
PubChem for drug discovery and chemical biology
PubChem for drug discovery and chemical biologyPubChem for drug discovery and chemical biology
PubChem for drug discovery and chemical biology
Chris Southan
 
Will the real proteins please stand up
Will the real proteins please stand upWill the real proteins please stand up
Will the real proteins please stand up
Chris Southan
 
Peptide Tribulations
Peptide TribulationsPeptide Tribulations
Peptide Tribulations
Chris Southan
 
Looking at chemistry - protein - papers connectivity in ELIXIR
Looking at chemistry - protein - papers connectivity in ELIXIRLooking at chemistry - protein - papers connectivity in ELIXIR
Looking at chemistry - protein - papers connectivity in ELIXIR
Chris Southan
 
Guide to Immunopharmacology update
Guide to Immunopharmacology updateGuide to Immunopharmacology update
Guide to Immunopharmacology update
Chris Southan
 
Peptide Tribulations in GtoPdb
Peptide Tribulations in GtoPdbPeptide Tribulations in GtoPdb
Peptide Tribulations in GtoPdb
Chris Southan
 

More from Chris Southan (20)

FAIR connectivity for DARCP
FAIR  connectivity for DARCPFAIR  connectivity for DARCP
FAIR connectivity for DARCP
 
Connectivity > documents > structures > bioactivity
Connectivity > documents > structures > bioactivityConnectivity > documents > structures > bioactivity
Connectivity > documents > structures > bioactivity
 
Peptide tribulations
Peptide tribulationsPeptide tribulations
Peptide tribulations
 
Vicissitudes of target validation for BACE1 and BACE2
Vicissitudes of target validation for BACE1 and BACE2 Vicissitudes of target validation for BACE1 and BACE2
Vicissitudes of target validation for BACE1 and BACE2
 
Guide to Pharmacology database: ELIXIR updae
Guide to Pharmacology database: ELIXIR updaeGuide to Pharmacology database: ELIXIR updae
Guide to Pharmacology database: ELIXIR updae
 
In silico 360 Analysis for Drug Development
In silico 360 Analysis for Drug DevelopmentIn silico 360 Analysis for Drug Development
In silico 360 Analysis for Drug Development
 
Will the correct BACE ORFs please stand up?
Will the correct BACE ORFs please stand up?Will the correct BACE ORFs please stand up?
Will the correct BACE ORFs please stand up?
 
Desperately seeking DARCP
Desperately seeking DARCPDesperately seeking DARCP
Desperately seeking DARCP
 
Seeking glimmers of light in Pharos “Tdark” proteins
Seeking glimmers of light in  Pharos “Tdark” proteinsSeeking glimmers of light in  Pharos “Tdark” proteins
Seeking glimmers of light in Pharos “Tdark” proteins
 
5HT2A modulators update for SAFER
5HT2A modulators update for SAFER5HT2A modulators update for SAFER
5HT2A modulators update for SAFER
 
Quality and noise in big chemistry databases
Quality and noise in big chemistry databasesQuality and noise in big chemistry databases
Quality and noise in big chemistry databases
 
Connecting chemistry-to-biology
Connecting chemistry-to-biology Connecting chemistry-to-biology
Connecting chemistry-to-biology
 
GtoPdb June 2019 poster
GtoPdb June 2019 posterGtoPdb June 2019 poster
GtoPdb June 2019 poster
 
PubChem as a source of systems biology perturbagens
PubChem as a source of  systems biology perturbagensPubChem as a source of  systems biology perturbagens
PubChem as a source of systems biology perturbagens
 
PubChem for drug discovery and chemical biology
PubChem for drug discovery and chemical biologyPubChem for drug discovery and chemical biology
PubChem for drug discovery and chemical biology
 
Will the real proteins please stand up
Will the real proteins please stand upWill the real proteins please stand up
Will the real proteins please stand up
 
Peptide Tribulations
Peptide TribulationsPeptide Tribulations
Peptide Tribulations
 
Looking at chemistry - protein - papers connectivity in ELIXIR
Looking at chemistry - protein - papers connectivity in ELIXIRLooking at chemistry - protein - papers connectivity in ELIXIR
Looking at chemistry - protein - papers connectivity in ELIXIR
 
Guide to Immunopharmacology update
Guide to Immunopharmacology updateGuide to Immunopharmacology update
Guide to Immunopharmacology update
 
Peptide Tribulations in GtoPdb
Peptide Tribulations in GtoPdbPeptide Tribulations in GtoPdb
Peptide Tribulations in GtoPdb
 

Recently uploaded

Testing the Son of God Hypothesis (Jesus Christ)
Testing the Son of God Hypothesis (Jesus Christ)Testing the Son of God Hypothesis (Jesus Christ)
Testing the Son of God Hypothesis (Jesus Christ)
Robert Luk
 
Probing the northern Kaapvaal craton root with mantle-derived xenocrysts from...
Probing the northern Kaapvaal craton root with mantle-derived xenocrysts from...Probing the northern Kaapvaal craton root with mantle-derived xenocrysts from...
Probing the northern Kaapvaal craton root with mantle-derived xenocrysts from...
James AH Campbell
 
BIOPHYSICS Interactions of molecules in 3-D space-determining binding and.pptx
BIOPHYSICS Interactions of molecules in 3-D space-determining binding and.pptxBIOPHYSICS Interactions of molecules in 3-D space-determining binding and.pptx
BIOPHYSICS Interactions of molecules in 3-D space-determining binding and.pptx
alishyt102010
 
Collaborative Team Recommendation for Skilled Users: Objectives, Techniques, ...
Collaborative Team Recommendation for Skilled Users: Objectives, Techniques, ...Collaborative Team Recommendation for Skilled Users: Objectives, Techniques, ...
Collaborative Team Recommendation for Skilled Users: Objectives, Techniques, ...
Hossein Fani
 
Molecular biology of abiotic stress tolerence in plants
Molecular biology of abiotic stress tolerence in plantsMolecular biology of abiotic stress tolerence in plants
Molecular biology of abiotic stress tolerence in plants
rushitahakik1
 
Science grade 09 Lesson1-2 NLC-pptx.pptx
Science grade 09 Lesson1-2 NLC-pptx.pptxScience grade 09 Lesson1-2 NLC-pptx.pptx
Science grade 09 Lesson1-2 NLC-pptx.pptx
JoanaBanasen1
 
SCIENCEgfvhvhvkjkbbjjbbjvhvhvhvjkvjvjvjj.pptx
SCIENCEgfvhvhvkjkbbjjbbjvhvhvhvjkvjvjvjj.pptxSCIENCEgfvhvhvkjkbbjjbbjvhvhvhvjkvjvjvjj.pptx
SCIENCEgfvhvhvkjkbbjjbbjvhvhvhvjkvjvjvjj.pptx
WALTONMARBRUCAL
 
ScieNCE grade 08 Lesson 1 and 2 NLC.pptx
ScieNCE grade 08 Lesson 1 and 2 NLC.pptxScieNCE grade 08 Lesson 1 and 2 NLC.pptx
ScieNCE grade 08 Lesson 1 and 2 NLC.pptx
JoanaBanasen1
 
degree Certificate of Aston University
degree Certificate of Aston Universitydegree Certificate of Aston University
degree Certificate of Aston University
ebgyz
 
Protein Digestion123334444556678890.pptx
Protein Digestion123334444556678890.pptxProtein Digestion123334444556678890.pptx
Protein Digestion123334444556678890.pptx
muralinath2
 
Computer aided biopharmaceutical characterization
Computer aided biopharmaceutical characterizationComputer aided biopharmaceutical characterization
Computer aided biopharmaceutical characterization
souravpaul769171
 
SlideEgg-703870-Bird Migration PPT Presentation.pptx
SlideEgg-703870-Bird Migration PPT Presentation.pptxSlideEgg-703870-Bird Migration PPT Presentation.pptx
SlideEgg-703870-Bird Migration PPT Presentation.pptx
randaalmabrouk
 
The National Research Platform Enables a Growing Diversity of Users and Appl...
The National Research Platform Enables a Growing Diversity of Users and Appl...The National Research Platform Enables a Growing Diversity of Users and Appl...
The National Research Platform Enables a Growing Diversity of Users and Appl...
Larry Smarr
 
gastrointestinal hormonese I 45678633134668097636903278.pptx
gastrointestinal hormonese I 45678633134668097636903278.pptxgastrointestinal hormonese I 45678633134668097636903278.pptx
gastrointestinal hormonese I 45678633134668097636903278.pptx
muralinath2
 
Search for Dark Matter Ionization on the Night Side of Jupiter with Cassini
Search for Dark Matter Ionization on the Night Side of Jupiter with CassiniSearch for Dark Matter Ionization on the Night Side of Jupiter with Cassini
Search for Dark Matter Ionization on the Night Side of Jupiter with Cassini
Sérgio Sacani
 
Science-Technology Quiz (School Quiz 2024)
Science-Technology Quiz (School Quiz 2024)Science-Technology Quiz (School Quiz 2024)
Science-Technology Quiz (School Quiz 2024)
Kashyap J
 
Electrostatic force class 8 ncert. .pptx
Electrostatic force class 8 ncert. .pptxElectrostatic force class 8 ncert. .pptx
Electrostatic force class 8 ncert. .pptx
yokeswarikannan123
 
poikilocytosis 23765437865210857453257844.pptx
poikilocytosis 23765437865210857453257844.pptxpoikilocytosis 23765437865210857453257844.pptx
poikilocytosis 23765437865210857453257844.pptx
muralinath2
 
Liver & Gall Bladder 23098463278654387654328765439875.pptx
Liver & Gall Bladder 23098463278654387654328765439875.pptxLiver & Gall Bladder 23098463278654387654328765439875.pptx
Liver & Gall Bladder 23098463278654387654328765439875.pptx
muralinath2
 
SCIENTIFIC INVESTIGATIONS – THE IMPORTANCE OF FAIR TESTING.pptx
SCIENTIFIC INVESTIGATIONS – THE IMPORTANCE OF FAIR TESTING.pptxSCIENTIFIC INVESTIGATIONS – THE IMPORTANCE OF FAIR TESTING.pptx
SCIENTIFIC INVESTIGATIONS – THE IMPORTANCE OF FAIR TESTING.pptx
JoanaBanasen1
 

Recently uploaded (20)

Testing the Son of God Hypothesis (Jesus Christ)
Testing the Son of God Hypothesis (Jesus Christ)Testing the Son of God Hypothesis (Jesus Christ)
Testing the Son of God Hypothesis (Jesus Christ)
 
Probing the northern Kaapvaal craton root with mantle-derived xenocrysts from...
Probing the northern Kaapvaal craton root with mantle-derived xenocrysts from...Probing the northern Kaapvaal craton root with mantle-derived xenocrysts from...
Probing the northern Kaapvaal craton root with mantle-derived xenocrysts from...
 
BIOPHYSICS Interactions of molecules in 3-D space-determining binding and.pptx
BIOPHYSICS Interactions of molecules in 3-D space-determining binding and.pptxBIOPHYSICS Interactions of molecules in 3-D space-determining binding and.pptx
BIOPHYSICS Interactions of molecules in 3-D space-determining binding and.pptx
 
Collaborative Team Recommendation for Skilled Users: Objectives, Techniques, ...
Collaborative Team Recommendation for Skilled Users: Objectives, Techniques, ...Collaborative Team Recommendation for Skilled Users: Objectives, Techniques, ...
Collaborative Team Recommendation for Skilled Users: Objectives, Techniques, ...
 
Molecular biology of abiotic stress tolerence in plants
Molecular biology of abiotic stress tolerence in plantsMolecular biology of abiotic stress tolerence in plants
Molecular biology of abiotic stress tolerence in plants
 
Science grade 09 Lesson1-2 NLC-pptx.pptx
Science grade 09 Lesson1-2 NLC-pptx.pptxScience grade 09 Lesson1-2 NLC-pptx.pptx
Science grade 09 Lesson1-2 NLC-pptx.pptx
 
SCIENCEgfvhvhvkjkbbjjbbjvhvhvhvjkvjvjvjj.pptx
SCIENCEgfvhvhvkjkbbjjbbjvhvhvhvjkvjvjvjj.pptxSCIENCEgfvhvhvkjkbbjjbbjvhvhvhvjkvjvjvjj.pptx
SCIENCEgfvhvhvkjkbbjjbbjvhvhvhvjkvjvjvjj.pptx
 
ScieNCE grade 08 Lesson 1 and 2 NLC.pptx
ScieNCE grade 08 Lesson 1 and 2 NLC.pptxScieNCE grade 08 Lesson 1 and 2 NLC.pptx
ScieNCE grade 08 Lesson 1 and 2 NLC.pptx
 
degree Certificate of Aston University
degree Certificate of Aston Universitydegree Certificate of Aston University
degree Certificate of Aston University
 
Protein Digestion123334444556678890.pptx
Protein Digestion123334444556678890.pptxProtein Digestion123334444556678890.pptx
Protein Digestion123334444556678890.pptx
 
Computer aided biopharmaceutical characterization
Computer aided biopharmaceutical characterizationComputer aided biopharmaceutical characterization
Computer aided biopharmaceutical characterization
 
SlideEgg-703870-Bird Migration PPT Presentation.pptx
SlideEgg-703870-Bird Migration PPT Presentation.pptxSlideEgg-703870-Bird Migration PPT Presentation.pptx
SlideEgg-703870-Bird Migration PPT Presentation.pptx
 
The National Research Platform Enables a Growing Diversity of Users and Appl...
The National Research Platform Enables a Growing Diversity of Users and Appl...The National Research Platform Enables a Growing Diversity of Users and Appl...
The National Research Platform Enables a Growing Diversity of Users and Appl...
 
gastrointestinal hormonese I 45678633134668097636903278.pptx
gastrointestinal hormonese I 45678633134668097636903278.pptxgastrointestinal hormonese I 45678633134668097636903278.pptx
gastrointestinal hormonese I 45678633134668097636903278.pptx
 
Search for Dark Matter Ionization on the Night Side of Jupiter with Cassini
Search for Dark Matter Ionization on the Night Side of Jupiter with CassiniSearch for Dark Matter Ionization on the Night Side of Jupiter with Cassini
Search for Dark Matter Ionization on the Night Side of Jupiter with Cassini
 
Science-Technology Quiz (School Quiz 2024)
Science-Technology Quiz (School Quiz 2024)Science-Technology Quiz (School Quiz 2024)
Science-Technology Quiz (School Quiz 2024)
 
Electrostatic force class 8 ncert. .pptx
Electrostatic force class 8 ncert. .pptxElectrostatic force class 8 ncert. .pptx
Electrostatic force class 8 ncert. .pptx
 
poikilocytosis 23765437865210857453257844.pptx
poikilocytosis 23765437865210857453257844.pptxpoikilocytosis 23765437865210857453257844.pptx
poikilocytosis 23765437865210857453257844.pptx
 
Liver & Gall Bladder 23098463278654387654328765439875.pptx
Liver & Gall Bladder 23098463278654387654328765439875.pptxLiver & Gall Bladder 23098463278654387654328765439875.pptx
Liver & Gall Bladder 23098463278654387654328765439875.pptx
 
SCIENTIFIC INVESTIGATIONS – THE IMPORTANCE OF FAIR TESTING.pptx
SCIENTIFIC INVESTIGATIONS – THE IMPORTANCE OF FAIR TESTING.pptxSCIENTIFIC INVESTIGATIONS – THE IMPORTANCE OF FAIR TESTING.pptx
SCIENTIFIC INVESTIGATIONS – THE IMPORTANCE OF FAIR TESTING.pptx
 

The IUPHAR/MMV Guide to Malaria Pharmacology

  • 1. Capturing drugs, leads and targets in the IUPHAR/MMV Guide to Malaria Pharmacology C. Southan1, J. F. Armstrong1, E. Faccenda1, S. D. Harding1, J. L. Sharman1, A. J. Pawson1, J Gamo2,3 B Campo2, J. A. Davies1 M. Spedding4, S.P.H. Alexander4 1) IUPHAR/BPS Guide to Pharmacology, Centre for Discovery Brain Sciences, University of Edinburgh, UK., 2) Medicines for Malaria Venture, Geneva, Switzerland, 3) Tres Cantos Medicines Development Campus, GlaxoSmithKline, Spain, 4) International Union of Basic & Clinical Pharmacology (IUPHAR) 1 World Congress of Pharmacology, Kyoto, Global Infectious Diseases session, Wednesday, July 4, 2018
  • 2. Abstract (will not be presented) Introduction: GtoPdb has been traditionally focused on the pharmacology associated with non-infectious diseases. However, in October of 2017 we initiated a collaboration with Medicines for MalariaVenture (MMV) in Geneva, where we have been piloting the curation of antimalarial compounds and Plasmodium targets for approved drugs and the global portfolio of new clinical candidates and research leads .This will provide explicit mappings between compounds and targets for current and new antimalarials. Methods:The main method is mining primary literature, review articles to collate an open CiteUlike tagged collection . For database entries, drugs and leads are prioritised for having a) specific chemical structure, b) a reported potency for antimalarial activity in vitro and, where possible c) activity data against the purified Plasmodium target and d) in vivo/ clinical data. We map chemical structures to PubChemCompound Identifiers (CIDs) and assign Plasmodium target proteins to UniProt accession numbers. These are accommodated within GtoPdb under a new classification of “antinfective targets” Results: We have successfully adapted GtoPdb data model for Plasmodium target mapping. However, sub- species and strain isolates may produce equivocality as to the exact sequence targeted. Whilst some publications are from open drug discovery practitioners, we can map most lead compounds to their corresponding patents via SureChEMBL. We can also accommodate lead structures with unknown mechanisms of parasite killing. Our first curated leads have been submitted to PubChem (e.g. SID 340590277 against N- Myristoyltransferase, UniProt Q8ILW6) Conclusion We have curated antimalarial relationship mappings into GtoPdb and surfaced these in our public release. We are now expanding to triage more publications. Our initiative enhances the facility with which the antimalarial community can access lead, target and efficacy data integrated between disparate global R&D efforts.This will support reciprocal cross-screening of leads for mechanistic investigations, target deconvolution, 3D structures and homology-based cross-screening directed against apicomplexan parasites. 2
  • 3. Overview of Guide to PHARMACOLOGY (GtoPdb) expert curated relationships (PMID 29149325 and poster PO2-8-11) • Total number of ligands = 9251 • Ligands with PubChem chemical structure entries (C) = 7070 • PubMed IDs associated with these by us (D) = 8109 • Human targets with quantitative interactions (P) = 1467 • Number of curated binding constants (R) = 15851 • Data from release 2018.2 http://www.guidetopharmacology.org/about.jsp 3 Document > assay > result > compound > location > protein target D- A- R - C- L- P
  • 4. Motivation for establishing the IUPHAR/MMV Guide to Malaria Pharmacology (GtoMPdb) • Engagement by MMV, their collaborators and many research teams globaly, some with an Open Source Drug Discovery modus operandi, has accelerated the generation of new antimalarial leads and clinical candidates • However, finding links between publications, code names, chemical structures, activity data and molecular mechanisms of action (mmoa), (including Plasmodium target sequences) is challenging • It remains an anachronism that neither authors nor journals submit chemical structures, code names or target associations of new antimalarials to databases • These “lost linkages” have problematic consequences, e.g. hindering data- mining, exchange of compounds for cross-screening, omics profiling and deconvolution of unknown mmoa • The GtoPdb data model has already proved flexible in its adaptation to the Guide to Immunopharmacology and pilot studies indicated that curated antimalarial relationships could also be accomodated 4
  • 5. Using CiteUlike for open pre-curation 5
  • 6. Database example for OSM-S-38 6
  • 10. Ligand matches to PubChem entries • All 28 curated ligands so far • We will submit these, including future novels • They will get PubMed links for our references • Query “Guide to Malaria Pharmacology” will retrieve our submissions • 22 are ”Rule of 5” • 4 are not in ChEMBL • 26 have SureChEMBL patent extraction matches • Only 15 are tagged ”Antimalarials” in PubChem • 14 have vendor matches • Some do not have the code numbers we have matched (but will when we submit) 10
  • 11. Data-supported targets vs unknown mmoa 11 Target proteins with direct binding data, strong genetic inference or cell screening evidence From the current 28 ligands the mechanistic target evidence: unknown mmoa is ~ 2:1 (but this is shifting as curation proceeds)
  • 12. Achievments and plans • Adapting the GtoPdb schema and expert curation approaches to antimalarial compounds and targets has been sucessful • We hope this systematic ”global portfolio” capture will contribute to progress • The first set of records wil go live in GtoPdb release ~July 2018 and then be submitted to PubChem • Develpment of the Alpha portal is progressing via feedback from MMV, a constituted Expert Commitee and initial users • Some malaria-specific challenges still need optimisation, e.g. separating IC50 potency for parasite killing in vivo from inhibition IC50 against purified targets in vitro • CiteUlike capture and curation of mechanistic papers • The comunity can alert us to new antimalarial lead papers (e.g. use our open CiteUlike tags) • Consider pre-publication capture (e.g. Sydney Open Source Malaria team) • Check for patents with new SAR not yet in journals 12